查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
Roche navify Tumor Board (2023)：透过整体数据视图改进肿瘤委员会会议，以促进多学科团队协作并优化治疗决策
市场调查报告书
商品编码
1381003

Roche navify Tumor Board (2023)：透过整体数据视图改进肿瘤委员会会议，以促进多学科团队协作并优化治疗决策

Roche navify Tumor Board 2023: Improving Tumor Board Meetings with a Holistic View of Data That Facilitates Multidisciplinary Team Collaboration and Optimizes Care Decisions
出版日期: | 出版商: KLAS Research | 英文 5 Pages | 商品交期: 最快1-2个工作天内

价格
如有价格方面的疑问请按下「询问」键来信查询
简介目录

肿瘤委员会会议在癌症患者的全面有效管理中发挥重要作用。这次会议将涉及多学科团队共同评估复杂的癌症病例并做出明智的个人化治疗决策。如果没有肿瘤板技术，有效的沟通、协作、数据共享和决策可能会受到阻碍，导致延误、不准确和次优护理。罗氏旨在透过 navify Tumor Board 解决这些潜在问题。

本报告提供Roche Diagnostics所提供的解决方案，以navify Tumor Board为焦点，并调查使用过此解决方案的客户的第一印象和客户体验。

目录

第1章 navify Tumor Board:客户体验 (CX) - 第一印象

第2章 应该考虑的点

第3章 Roche Diagnostics:企业简介

第4章 解决方案的技术规格 (Roche Diagnostics提供)

简介目录

Tumor board conferences play a crucial role in the comprehensive, effective management of cancer patients. These meetings involve a multidisciplinary team that collectively evaluates complex cancer cases and collaborates to make informed, personalized treatment decisions. The absence of tumor board technology can hinder effective communication, collaboration, data sharing, and decision-making, which potentially leads to delays, inaccuracies, and suboptimal care. Roche aims to solve these potential problems with navify Tumor Board. This report offers an initial look at customers' experiences with this product.

Table of Contents

1.) navify Tumor Board Customer Experience: An Initial Look

2.) Points to Ponder

3.) Roche Diagnostics: Company Profile at a Glance

4.) Solution Technical Specifications (provided by Roche Diagnostics)